GLP1R and neoplasm: Certain tumor lineages had a higher proportion of GLP-1R+ cell lines including pancreas (63.6%, n=55), myeloid (60.4%, n=73), peripheral nervous system (60%, n=45), lung (54.9%, n=213), breast (51.4%, n= 70), and lymphoid (37.9%, n=187).